Aktieanalys

Active Biotech Q1’22: Our comments and updated valuation - Redeye

{newsItem.title}

Redeye Publicerad: 22 Apr 2022 11:06

Redeye comments on Active Biotech’s first quarter report and updates its valuation and forecast.

Länk till analysen i sin helhet: https://www.redeye.se/research/838916/active-biotech-q122-our-comments-and-updated-forecast?utm_source=finwire&utm_medium=RSS

Nyheter om Active Biotech

Läses av andra just nu

Om aktien Active Biotech

Senaste nytt